AC Immune (ACIU) Prepaid Assets (2014 - 2026)
AC Immune (ACIU) posted quarterly Prepaid Assets of $4.8 billion for Q1 2026, up 119073.46% year-over-year from N/an in Q1 2025, and down 3.79% quarter-over-quarter from $5.0 billion in Q4 2025.
Analysis
AC Immune (ACIU) Prepaid Assets (2014 - 2026) Analysis & Trends
AC Immune (ACIU) has reported Prepaid Assets for 13 consecutive years, with $4.8 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 119073.46% year-over-year to $4.8 billion; the TTM figure through Mar 2026 stood at $4.8 billion (up 119073.46% YoY), while the FY2025 annual figure was $4.8 billion, up 97454.7% from the prior year.
- Prepaid Assets eased to $4.8 billion in Q1 2026 per ACIU's latest filing, from $5.0 billion in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.3 billion in Q4 2023 and bottomed at $3.0 million in Q3 2022.
- Historically, Prepaid Assets has averaged $1.4 billion across 5 years, with a median of $4.9 million in 2024.
- Annual changes were most pronounced in 2023 — Prepaid Assets jumped 148391.31% — and 2024, when it tumbled 99.93%.
- AC Immune's Prepaid Assets stood at $4.9 million in 2022, then surged by 148391.31% to $7.3 billion in 2023, then sank by 99.93% to $4.9 million in 2024, then jumped by 101097.75% to $5.0 billion in 2025, then slipped by 3.79% to $4.8 billion in 2026.
- Business Quant data shows ACIU's Prepaid Assets at $4.8 billion in Q1 2026, $5.0 billion in Q4 2025, and $4.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | AC Immune | 285.13 Mn | 285.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.57 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 4.97 Mn |
| Sep 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 4.01 Mn |
| Dec 31, 2024 | 4.91 Mn |
| Sep 30, 2024 | 3.98 Mn |
| Jun 30, 2024 | 4.27 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 7.26 Mn |
| Sep 30, 2023 | 6.27 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 5.88 Mn |
| Dec 31, 2022 | 4.89 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 3.04 Mn |
| Dec 31, 2021 | 3.27 Mn |
| Sep 30, 2021 | 2.11 Mn |